Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction

BACKGROUND: In patients with cardiogenic shock (CS), acute myocardial infarction (AMI) is the most common cause, and a percutaneous microaxial ventricular assist device (Impella, Abiomed, Danvers, MA) is a choice for temporary mechanical circulatory support. However, data are limited on complication...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Yuichi, Tateishi, Kazuya, Toda, Koichi, Matsumiya, Goro, Kobayashi, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547360/
https://www.ncbi.nlm.nih.gov/pubmed/37646217
http://dx.doi.org/10.1161/JAHA.123.030819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547360/
https://www.ncbi.nlm.nih.gov/pubmed/37646217
http://dx.doi.org/10.1161/JAHA.123.030819

Ejemplares similares